As of August 28, 2026, Amylyx Pharmaceuticals, Inc. (AMLX) has a DilutionWatch DilutionScore of 27/100, rated MEDIUM dilution risk. Amylyx Pharmaceuticals, Inc. has a market capitalization of $1.60B, 111.42M shares outstanding, 174 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for AMLX.
Market Data
Market Cap$1.60B
Shares Outstanding111.42M
Float83.53M
Cash$284.14M
Debt$5.63M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 20.3% shares (2026Q1 vs prior)
174 institutional holders · 141.95M shares
#1
FMR LLC
16.63M shares
#2
PERCEPTIVE ADVISORS LLC
16.57M shares
#3
JANUS HENDERSON GROUP PLC
9.97M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest13.40M
Days to Cover6.8
% of Float16.0%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2022-12-31
4
INSIDER TRANSACTION
2026-03-09
4
INSIDER TRANSACTION
2026-03-09
4
INSIDER TRANSACTION
2026-03-09
4
INSIDER TRANSACTION
2026-03-09
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual AMLX Dilution Snapshot
Amylyx Pharmaceuticals, Inc. (AMLX) has a DilutionScore of 27/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for AMLX: 4 on 2026-03-09; 4 on 2026-03-09; 4 on 2026-03-09.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track AMLX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AMLX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for AMLX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.